YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs.  The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.

Form Of Proxy For The Annual General Meeting To Be Held On Thursday, 29 May 2025
 (Or Any Adjournment Thereof)

Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period]

Notice Of 2025 Annual General Meeting

2024 Report Of The Board Of Directors
2024 Report Of The Board Of Supervisors
2024 Consolidated Financial Statements
2024 Annual Report
Re-Appointment Of The Auditor Of The Company
And
Notice Of Annual General Meeting

Financial Statements/ESG Information - [Environmental, Social and Governance Information/Report]

2024 Environmental, Social And Governance Report

Financial Statements/ESG Information - [Annual Report]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Yichang HEC Changjiang Pharma (1558 HK)

Form Of Proxy For The Annual General Meeting To Be Held On Thursday, 29 May 2025 (Or Any Adjournment Thereof)

Notice Of 2025 Annual General Meeting

2024 Report Of The Board Of Directors 2024 Report Of The Board Of Supervisors 2024 Consolidated Financial Statements 2024 Annual Report Re-Appointment Of The Auditor Of The Company And Notice Of Annual General Meeting

2024 Environmental, Social And Governance Report

Annual Report 2024

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)